A random six-phase switch regulates pneumococcal virulence via global epigenetic changes by Manso, A. et al.
PUBLISHED VERSION 
Ana Sousa Manso, Melissa H. Chai, John M. Atack, Leonardo Furi, Megan De Ste Croix, Richard 
Haigh, Claudia Trappetti, Abiodun D. Ogunniyi, Lucy K. Shewell, Matthew Boitano, Tyson A. Clark, 
Jonas Korlach, Matthew Blades, Evgeny Mirkes, Alexander N. Gorban, James C. Paton, Michael 
P. Jennings, Marco R. Oggioni 
A random six-phase switch regulates pneumococcal virulence via global epigenetic 
changes 
Nature Communications, 2014; 5:5055-1-5055-9 
 
 
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative 
Commons license, users will need to obtain permission from the license holder to reproduce the 































14 September, 2015 
ARTICLE
Received 19 Mar 2014 | Accepted 21 Aug 2014 | Published 30 Sep 2014
A random six-phase switch regulates
pneumococcal virulence via global
epigenetic changes
Ana Sousa Manso1,2, Melissa H. Chai3, John M. Atack4, Leonardo Furi1,2, Megan De Ste Croix1,
Richard Haigh1, Claudia Trappetti3, Abiodun D. Ogunniyi3, Lucy K. Shewell4, Matthew Boitano5,
Tyson A. Clark5, Jonas Korlach5, Matthew Blades6, Evgeny Mirkes7, Alexander N. Gorban7, James C. Paton3,
Michael P. Jennings4,* & Marco R. Oggioni1,2,*
Streptococcus pneumoniae (the pneumococcus) is the world’s foremost bacterial pathogen in
both morbidity and mortality. Switching between phenotypic forms (or ‘phases’) that favour
asymptomatic carriage or invasive disease was ﬁrst reported in 1933. Here, we show that the
underlying mechanism for such phase variation consists of genetic rearrangements in a Type I
restriction-modiﬁcation system (SpnD39III). The rearrangements generate six alternative
speciﬁcities with distinct methylation patterns, as deﬁned by single-molecule, real-time
(SMRT) methylomics. The SpnD39III variants have distinct gene expression proﬁles. We
demonstrate distinct virulence in experimental infection and in vivo selection for switching
between SpnD39III variants. SpnD39III is ubiquitous in pneumococci, indicating an essential
role in its biology. Future studies must recognize the potential for switching between these
heretofore undetectable, differentiated pneumococcal subpopulations in vitro and in vivo.
Similar systems exist in other bacterial genera, indicating the potential for broad exploitation
of epigenetic gene regulation.
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T
he importance of Streptococcus pneumoniae as a human
pathogen has prompted intense investigation in the post
genomics era, with more genome sequences available than
for most other species1. In spite of this, much remains to be
elucidated regarding the molecular basis of critical virulence
attributes, including the phenomenon of opacity phase variation
(high frequency, reversible switching of expression)2,3.
Examination of multiple genomes has failed to identify
nucleotide polymorphisms or accessory regions that could be
consistently associated with virulence phenotypes; however, such
studies have ignored the potential of restriction-modiﬁcation
(RM) systems to mediate gene regulation via epigenetic
changes4,5. The S. pneumoniae genome contains two Type I,
three Type II and one Type IV RM systems6,7; of these, only the
DpnI Type II RM system has been described in detail in the past8.
One of the Type I RM systems, which we propose to name
SpnD39III according to REBASE criteria, contains three co-
transcribed genes: hsdR, hsdM and hsdS (coding for SpnD39III,
M.SpnD39III and S3.SpnD39III); there is also a separately
transcribed Cre tryrosine DNA recombinase gene and two
truncated hsdS genes (S1.SpnD39III and S2.SpnD39III)
downstream5,9. The actively transcribed hsdS gene contains two
variable regions that encode the two target recognition domains
(TRD) of S.SpnD39III, and it shares inverted repeats with the
truncated hsdS genes; these truncated genes encode additional,
separate alleles for both TRDs, but lack consensus hsdS 50 ends,
ribosomal binding sites and promoters. The series of inverted
repeat regions in the hsdS genes had been shown to enable
recombination, thought to be facilitated by the CreX
recombinase, potentially generating alternative hsdS variants
encoding enzymes with different target speciﬁcities6,10. Similar
phase variable Type I RM systems have been described in
Bacteroides fragilis and Mycoplasma pulmonis11,12.
Here, we show that recombination between hsdS genes confers
six different target speciﬁcities to the Type I SpnD39III RM
system and that this has signiﬁcant impact on gene expression
and virulence of pneumococci.
Results
Characterization of the SpnD39III RM system. To characterize
the SpnD39III RM enzyme, we constructed mutants in the viru-
lent pneumococcal strain D39 each expressing only one of the six
possible hsdS variants (Fig. 1, Table 1). The strains are designated
SpnD39IIIA-F and are characterized by a single S.SpnD39IIIA-F
variant, respectively, referred to as ‘locked’ strains (Fig. 1, Table 1).
Mutants were constructed by deleting the truncated hsdS genes
downstream of the actively transcribed locus and selecting at least
one strain with a ‘locked’ s.spnD39III allele for each of the six
possible variants. Absence of any other mutation was conﬁrmed
by whole-genome sequencing. Single-molecule real-time (SMRT)
sequencing and methylome analysis13 identiﬁed distinct N6-
adenine methylation targets for each SpnD39IIIA-E variant
(Table 1, Supplementary Fig. 1). Methylome data of the locked
strains showed methylation in both strands of over 99% of the
target sites (Table 1, Supplementary Fig. 1). On the basis of these
results, each target recognition domain can be assigned to a
speciﬁc sequence that it is responsible for recognizing: the amino-
terminal (N-terminal) TRDs of SpnD39IIIA, IIIB and IIIE
(TRD1.1) recognize CRAA; the N-terminal TRDs of IIIC and
IIID (TRD1.2) recognize CAC; the carboxyl-terminal (C-terminal)
TRDs of IIIA and IIID (TRD2.1) recognize CTG; the C-terminal
TRDs of IIIB and IIIC (TRD2.2) recognize TTC; and the
C-terminal TRDs of IIIE (TRD2.3) recognize CTT (Table 1,
Fig. 1). Given the target speciﬁcities identiﬁed for SpnD39IIIA-E,
we could infer the target speciﬁcity also for SpnD39IIIFP, where
the P stands for putative10. Thus, by recombination between these
ﬁve different TRDs (TRD1.1 or 1.2 and TRD2.1, 2.2 or 2.3), six
different methylation speciﬁcities are possible. Three of these
bipartite target sites, a distinct feature of Type I enzymes, were
experimentally conﬁrmed with restriction inhibition assays using
plasmid DNA isolated from D39 strains containing locked
S.SpnD39IIIA, B or C enzymes (Supplementary Fig. 2a–c). The
SMRT methylome analysis of S. pneumoniae D39 also identiﬁed
two active Type II RM systems (SpnD39I—TCTAG[m6A]; and
SpnD39II—TCG[m6A]C). D39 contains a second Type I system
which is non-functional through truncation of the
SpnD39ORF782P gene (Table 1). However, methylome analysis
of S. pneumoniae clinical isolates WCH16 and WCH43 (ref. 14)
has allowed us to identify the equivalent Type I RM system
with two allelic variants of which also showing a potentially
phase variable methylase. This system contains variants A and B
that were found to methylate the sequences G(m6A)YN6TATC
and TG(m6A)N7TATC, respectively (Table 1). Examination
of all available bacterial genome sequences reveals similar
arrangements of hsdS genes in other genera, thus potentially
allowing for similar reversible switching in other species
(Supplementary Table 1)11,12.
SpnD39III target site distribution. Natural switching between
the six distinct S.SpnD39III variants resulted in different num-
bers, positions and types of methylation sites in the D39 genome;
they ranged in number from 424 sites (SpnD39IIID) to 1,029 sites
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Figure 1 | Schematic map of the SpnD39III locus and of the six
alternative hsdS genes. In strain D39, the Type I RM system SpnD39III
locus (upper row from right to left) includes hsdR (locus_tag SPD_0455;
GenBank protein database accession code ABJ53942; REBASE
SpnD39ORF782P), hsdM (SPD_0454; ABJ54850; M.SpnD39ORF454P)
and hsdS (SPD_0453; ABJ53819; S3.SpnD39ORF454P), a Cre recombinase
(SPD_0452; ABJ54057), a truncated hsdS0 gene with only one variable
domain (SPD_0450; ABJ55250; S2.SpnD39ORF454P) and a further
truncated hsdS0 0 gene with two variable domains (SPD_0451; ABJ54176;
S1.SpnD39ORF454P). Three series of inverted repeats (IR1 to IR3) allow for
recombination. These rearrangements, exempliﬁed by crosses between the
IRs, allow formation of six different variant hsdS alleles encoding different
HsdS proteins SpnD39IIIA-F. Inverted repeats are of 85 (IR1, striped), 333
(IR2, dotted) and 15 bp (IR3). The six recombinant s.spnD39IIIA-F alleles
(Genbank nucleotide database accession codes KJ955483, KJ955484,
KJ955485, KJ955486, KJ398403 and KJ398404) are shown below with
their TRDs numbered according to Table 1.
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nucleotide base occurrence in the D39 genome, differed sig-
niﬁcantly from those observed, with SpnD39IIIA, SpnD39IIIB
and SpnD39IIIE showing 50% more sites than predicted, and
SpnD39IIIC, SpnD39IIID and SpnD39IIIF being under-
represented (Table 1). Being non-palindromic, the SpnD39III
sites could be mapped to one of the two strands of the genome,
where the localization to one strand does not refer to the position
of the site but rather to the orientation of site and RM enzyme
complex. Intriguingly, we observed not only a marked preference
for all SpnD39III variants to be on the lagging strand (Pearson’s
w2-test, Po0.001) (Supplementary Fig. 3), but also that the
deviation seen between expected and observed sites mapped only
to one strand of the genome, that is, overrepresented sites were
overrepresented on the lagging strand and underrepresented sites
were underrepresented on the leading strand (Supplementary
Table 2). Furthermore, reciprocal positioning of the sites on the
leading and lagging strands of the genome showed a non-random
pattern for all SpnD39III sites except SpnD39IIIE
(Supplementary Tables 3 and 4). These observations were not
explained by the GC skew of the genome and were not observed
when testing classical representatives of Type I RM families A–C
such as EcoK1, EcoAI and EcoR124I (Supplementary Tables 2–4).
Interestingly, the target sites of Type III RM systems EcoP1I and
EcoP15I (shown to be most active in the presence of non-co-
directional, head-to-head oriented target sites)15 also showed
signiﬁcant non-random distribution between strands in the
genome, when tested either by nearest neighbour distribution
using the Clark–Evans test, or by target site pair distribution
using the Kolmogorov–Smirnov test (Supplementary Tables 2–4).
Although these calculations did not allow us to draw direct
conclusions on functionality, they indicated that the SpnD39III
site distribution pattern had more in common with Type III RM
systems, which have directional activity, than with the classical
Type I systems. An alternative conclusion could be that the
observed genome-wide asymmetric localization of nucleotide
signatures is associated with a functional role in replication or
transcription16. Bioinformatics analysis showed no obvious
association of the methylation target sites with promoters,
small RNAs, genes or operons. Out of the six variants,
SpnD39IIIA, SpnD39IIIB, SpnD39IIID and SpnD39IIIF
showed reduced occurrence in non-coding regions (Pearson’s
w2-test, Po0.001).
Evaluation of SpnD39III methylation and restriction activity.
To evaluate the mechanism of restriction by SpnD39III, we
extracted differently methylated forms of the shuttle vector
pDP28 from the locked SpnD39III strains (Supplementary Fig. 4)
and retransformed these plasmids into the different locked
SpnD39III strains (equivalent phage infection experiments are
currently not possible due to the lack of phage capable of
infecting encapsulated pneumococci). Reduced transformation
efﬁciencies, indicating restriction of incoming plasmid DNA,
were only observed when transforming heterologously methy-
lated plasmids into the SpnD39IIIB or SpnD39IIIC strains
(Fig. 2a–d). Importantly, the SpnD39IIIB and SpnD39IIIC sites of
pDP28 are non-co-directional unlike the SpnD39IIIA and
SpnD39IIID sites (Supplementary Fig. 4). These ﬁndings add
further to the novel nature of this system as the importance of
non-co-directional positioning of target sites has previously only
been reported for Type III RM systems4. We hypothesize that this
novel observation (directional restriction activity of a Type I RM
system) may be related to the peculiarity of our model test
system, which is based on the integration of non-methylated
single-stranded DNA into a resident rolling circle replicating
plasmid during natural transformation (see also the legend of
Table 1 | RM systems of pneumococcal strain D39.













Type II SPD_1630-1 50-GATC-30
30-CTAG-50
— — 7,164 7,324  2 —
SpnD39I
(SpnD39ORF1260P)
Type II SPD_1259-60 50-TCTAGA-30 30-AGATCT-50 — m6A 644 438 47y —
SpnD39II||
(SpnD39ORF1079AP)
Type II SPD_1079-80 50-TCGAG-30 30-AGCTG-50 — m6A 1,509 1454 4 —
SpnD39IIIA
(SpnD39ORF454P)
Type I SPD_0450-5 50-CRAAN8CTG-30
30-GYTTN8GAC-50
1.1, 2.1 m6A 720 438 64y 66y
SpnD39IIIB Type I SPD_0450-5 50-CRAAN9TTC-30
30-GYTTN9AAG-50
1.1, 2.2 m6A 1,029 665 55y 64y
SpnD39IIIC Type I SPD_0450-5 50-CACN8TTC-30
30-GTGN8AAG-50
1.2, 2.2 m6A 641 876  27y 66y
SpnD39IIID Type I SPD_0450-5 50-CACN7CTG-30
30-GTGN7GAC-50
1.2, 2.1 m6A 428 577  26y 67y
SpnD39IIIE Type I SPD_0450-5 50-CRAAN8CTT-30
30-GYTTN8GAA-50
1.1, 2.3 m6A 1,028 665 55y 63y
SpnD39IIIFP Type I SPD_0450-5 50-CACN7CTT-30
30-GTGN7GAA-50
1.2, 2.3 m6A 796 876  9y 64y
SpnD39ORF782P Type I SPD_0782-4z not active; see below — — — — — —
SpnD39McrBCP Type IV SPD_1108-9 not known — — — — —
ORF, open reading frame; RM, restriction-modiﬁcation system; TRD, target recognition domain.
Using strains WCH16 and WCH43 (ref. 14), we identiﬁed the target sites of the two possible variants of this Type I RM system to be 50-G(m6A)YN6TATC-30 and 30-CTRN6(m6A)TAG-50 for
S.SpnWCH16IVA (GenBank nucleotide database accession code KM030255) and 50-TG(m6A)N7TATC-30 and 30-ACTN7(m6A)TAG-50 for S. SpnWCH43IVB (GenBank code KM030256).
*Open reading frame (ORF) numbering and calculations are done for strain D39 (GenBank nucleotide database accession code CP000410.1).
wMethylated adenine in bold underlined.
zPercentage of sites mapping to the lagging strand of the genome (30-50 strand from start to 1,047,526 and 50-30 from 1,047,527 to end).
yDifferences were analysed by w2 analysis and found to be signiﬁcant for all values (Po0.001).
||The target site TCG(m6A)G could be associated to Spn39II due to absence of both this locus and TCG(m6A)G methylation in strain WCH43 (ref. 14).
zThe gene encoding S.SpnD39ORF782P is truncated in D39 and no methylation was detected.
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Supplementary Fig. 4). Indeed, no restriction could be observed
when transforming linear DNA with differently positioned
SpnD39IIIA sites into the chromosome (Supplementary Fig. 2f),
an observation that is more in line with what is expected during
natural transformation17. To further test our ﬁndings, we
constructed recombinant pDP28 derivatives containing either:
(i) non-co-directional SpnD39IIIA or SpnD39IIID sites, (ii) a
unique SpnD39IIIB site or (iii) co-directional SpnD39IIIC sites
(Supplementary Fig. 4b–d). Transformation of these plasmids
conﬁrmed that, in our speciﬁc model system at least, two non-co-
directional sites are needed for restriction (Fig. 2e–h). It is
possible therefore that the preferential co-directional site
distribution in the genome (see above) could indicate a selective
advantage in reducing risks of self-cleavage following switching
between SpnD39III alleles.
SpnD39III-dependent changes in gene expression. To
determine the global impact of the altered genomic methylation
patterns that result from switching between the alternate
SpnD39III speciﬁcities, we examined gene expression by RNA-
seq in four of the variants (SpnD39IIIA-D). In all locked strains,
changes in gene expression could be observed (the RNA-seq data
have been deposited in the NCBI GEO database with accession
code GSE55182). The most striking change was a downregulation
(relative to all other variants) of the capsule operon in
SpnD39IIIB. The polysaccharide capsule is a major pneumococcal
virulence determinant18. In addition, the dexB, luxS and SPD_310
genes, which are all located close to the capsule operon in the
genome, were also downregulated in SpnD39IIIB (Table 2). The
reduced production of LuxS and capsular polysaccharide in the
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Figure 2 | SpnD39III restriction. (a–h) Restriction by SpnD39III was demonstrated by transformation of differently methylated pDP28 plasmids into
strains expressing only one SpnD39III variant. Restriction was evident in strains expressing variant SpnD39IIIB (b) and SpnD39IIIC (c), which have non-co-
directional target sites on pDP28 (Supplementary Fig. 4), whereas restriction was not evident in strains expressing variants SpnD39IIIA (a) or SpnD39IIID
(d), which have co-directional target sites on pDP28. Graphs indicate s.d. of three independent replicates. Statistically signiﬁcant differences found using an
analysis of variance Tukey test are shown. When utilizing recombinant pDP28 derivatives with two non-co-directional target sites for SpnD39IIIA (e) or
SpnD39IIID (h) restriction could also be observed for these sites, whereas no restriction was observed when transforming a recombinant pDP28 with only
one SpnD39IIIB site (f) or two co-directional SpnD39IIIC sites (g). ***Po0.001.
Table 2 | Differential expression in the SpnD39IIIB variant strain relative to the other SpnD39III variants*.
D39 ORF Gene Description SpnIIIA SpnIIIC SpnIIID
SPD_0309 luxS LuxS S-ribosylhomocysteine lyase 4.9 4.2  3.8
SPD_0310 (unnamed) Uncharacterized protein 4.5 4.1 4.0
SPD_0311 dexB Glucan 1,6-alpha-glucosidase  3.4 4.6 4.5
SPD_0315 cps2A LCP capsule anchoring protein 4.0 4.3 4.2
SPD_0316 cps2B Tyrosine-protein phosphatase  3.1  3.2  3.1
SPD_0317 cps2C Polysaccharide transport protein  2.5  2.7  2.6
SPD_0318 cps2D Tyrosine-protein kinase  2.1  2.6  2.5
SPD_0321 cps2F Glycosyl transferase  2.3  2.7  2.6
SPD_0322 cps2G Glycosyl transferase  2.4  2.8  3.3
SPD_0323 csp2H Polysaccharide polymerase  2.2  2.6  2.9
SPD_0325 cps2J Membrane protein  2.9  3.0  3.9
SPD_0326 cps2K UDP-glucose 6-dehydrogenase  2.9  2.7  3.0
SPD_0327 cps2P UDP-galactopyranose mutase  2.6  3.3  3.9
SPD_0328 cps2L Glucose-1-P thymidylyltransferase  2.3  3.2 4.0
SPD_0330 rfbB dTDP-glucose 4,6-dehydratase  2.1  3.3 4.1
SPD_0331 rfbD dTDP-4-dehydrorhamnose reductase  2.1  3.0  3.7
SPD_0332 (unnamed) Uncharacterized protein  2.5  3.4  3.5
*Log2 fold change in gene expression as assessed by RNA-seq. Data are deposited in the NCBI GEO database with accession code GSE55182.
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and capsule assay, respectively (Fig. 3b,c). In SpnD39IIIA, the
blpY-SPD_0475 operon19, the sucrose regulator, and the fucose
operon were signiﬁcantly downregulated, and a series of genes,
including psaABC and dnaK, were upregulated relative to the
other three variants tested (Table 3). SpnD39IIIC and
SpnD39IIID strains did not show signiﬁcant differential
regulation of any other genes with respect to the other variants
under these assay conditions. No SpnD39III sites could be
identiﬁed in the promoter or regulatory regions of any of the
differentially regulated genes, so the exact method by which
differential methylation affects gene regulation patterns in the
pneumococcus remains to be elucidated (Tables 2 and 3). These
data do, however, show that genetic recombination at the
spnD39III locus results in a signiﬁcant impact on global
gene expression patterns via epigenetic mechanisms thereby
differentiating the pneumococcus into distinct cellular
phenotypes.
Phenotypic impact of SpnD39III phase variation. Certain
SpnD39III alleles also impacted on colony opacity. This mor-
phological feature is known to undergo reversible phase variation
between opaque (OP) and transparent (TP) phenotypes via an
unknown mechanism; the OP phenotype is preferentially asso-
ciated with invasive disease and TP with carriage3. The
SpnD39III-locked variant strains differed considerably in their
opacity: SpnD39IIIA and SpnD39IIIE strains yielded 100%
OP colonies; SpnD39IIIB 7% OP colonies; SpnD39IIIC 25%
OP colonies; SpnD39IIID 59% OP colonies; and SpnD39IIIF













































































































Figure 3 | In vitro phenotypes of SpnD39IIIA-F variant strains. (a) Phagocytosis of pneumococci by RAW 264.7 macrophages. Mean values of three
independent replicates and s.d. are shown. (b) LuxS expression was assayed by quantitative western blot and the mean of quadruplicate samples are shown
(in case of SpnD39E-F including two technical replicates). (c) The production of the type 2 polysaccharide capsule was quantiﬁed using an uronic acid
assay and the mean and s.d. of quadruplicate samples are shown (in case of SpnD39E-F including two technical replicates). Statistical analysis of in vitro
experiments (a–c) was performed using one-way analysis of variance and a Tukey post-comparison test. *Po0.05, **Po0.01, ***Po0.001.
Table 3 | Differential expression in the SpnD39IIIA variant strain*.
D39 ORF Gene Description SpnIIIB SpnIIIC SpnIIID
SPD_0257 Uncharacterized protein 2.4 2.2 2.6
SPD_0286 Glutathione peroxidase 2.4 2.7 2.2
SPD_0460 dnaKw Chaperone protein DnaK 2.8 2.5 2.7
SPD_0473 blpY Immunity protein BlpY  5.0 4.6  3.3
SPD_0474 Uncharacterized protein  5.6 4.8  3.1
SPD_0475 CAAX protease  5.3 4.5  2.9
SPD_0675 Uncharacterized protein  3.6  2.9  2.1
SPD_0708 Haloacid dehalogenase-like hydrolase  2.0  2.6  2.5
SPD_1256 Peptidase, U32 family protein  3.4  3.0  3.9
SPD_1307 w Uncharacterized protein  2.0  2.2  2.2
SPD_1415 Pyrimidine nucleotide sulﬁte reductase 2.3 2.7 3.6
SPD_1452 Uncharacterized protein  2.4  2.3  2.4
SPD_1461 psaB Manganese ABC transporter, ATP binding 2.8 2.9 2.6
SPD_1462 psaC Manganese ABC transporter, permease 3.0 3.0 2.7
SPD_1463 psaA Manganese, substrate-binding lipoprotein 2.6 2.9 2.7
SPD_1535 scrR Sucrose operon repressor  2.2  2.1  2.4
SPD_1992 PTS system, IIA component  2.7  2.6  2.4
SPD_1993 fucU L-fuculose transport protein  2.2  2.6  2.2
SPD_1994 fucA L-fuculose phosphate aldolase  2.2  2.5  2.0
SPD_1995 fucK L-fuculose kinase FucK  2.4  2.6  2.4
sRNA_F26 RNA downstream livJ 2.4 2.2 2.3
sRNA_SN46 RNA upstream pcpA 2.4 3.5 2.5
Data are deposited in the NCBI GEO database with accession code GSE55182.
*Log2 fold change in gene expression as assessed by RNA-seq.
wA SpnD39IIIA site maps in a non-coding RNA preceding the gene.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms6055 ARTICLE
NATURE COMMUNICATIONS | 5:5055 |DOI: 10.1038/ncomms6055 | www.nature.com/naturecommunications 5
& 2014 Macmillan Publishers Limited. All rights reserved.
distinct SpnD39III variant methylation patterns was therefore
investigated in murine models of nasopharyngeal colonization
and invasive disease. The locked SpnD39IIIA, unlike the other
variants or the D39 wild type, was unable to stably colonize the
nasopharynx (Fig. 4a–c; Supplementary Fig. 5). In contrast,
during invasive infection, those mice infected with the locked
SpnD39IIIB had lower bacterial counts in their blood at both 4
and 30 h after challenge than mice infected with the strains
expressing the other SpnD39III variants (Fig. 4d,e). At a later
time-point, the locked SpnD39IIIE and SpnD39IIIF strains also
showed lower virulence in this model (Fig. 4d,e). The lower
virulence of SpnD39IIIB is consistent with the lower capsule
expression seen in the gene expression studies (Table 2 and
Fig. 3c). Strains expressing SpnD39IIIB also showed an increased
susceptibility to phagocytosis by macrophages (Fig. 3a). Animals
challenged with SpnD39IIIA yielded almost exclusively OP
colonies when bacteria were isolated 30 h post challenge, while
animals challenged with SpnD39IIIB yielded mostly TP colonies
under the same conditions (Fig. 4f). Thus, differences in opacity
can be correlated with speciﬁc SpnD39III-locked-allele type;
SpnD39IIIA yielded mainly opaque colonies, showed high
virulence and therefore poor colonization capacity, whereas
SpnD39IIIB yielded mainly transparent colonies and had low
systemic virulence. It can therefore be concluded that SpnD39III-
mediated epigenetic modiﬁcation signiﬁcantly impacts on both
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Figure 4 | In vivo phenotypes of SpnD39IIIA-F variant strains. D39 wt or derivatives expressing only a locked SpnD39IIIA to SpnD39IIIF variant
were used in these experiments. Carriage experiments were performed by intranasal inoculation of 5 104 pneumococci into BALB/c mice, which are
resistant to invasive infection. (a–c) The extent of carriage was evaluated by nasal lavage at day 1 (a), day 3 (b) and day 7 (c). (d,e) In the invasive disease
model, susceptible CD1 mice received an intravenous challenge of 1 105 pneumococci, and blood samples were taken at 4 and 30h post challenge.
Statistical signiﬁcance of differing bacterial load in D39 wt or SpnD39III variant infected mice was calculated on log-transformed data using the unpaired
(two-tailed) t-test. (f) Blood samples plated directly onto catalase agar plates were examined and the percentage of opaque colonies observed for each
SpnD39III variant strain. (g,h) Allele quantiﬁcation in D39 wt was performed on DNA extracted from the nasal lavages of the carriage experiment (see also
Supplementary Table 5) or on DNA extracted from colonies grown from blood samples in the invasive disease experiment and SpnD39III variant
percentages for each are represented respectively in g (inoculum black, 1 day grey, 3 days white, and 7 days striped) and h (inoculum black, 4 h grey and
30h white). *Po0.05, **Po0.01, ***Po0.001.
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Quantiﬁcation of SpnD39III subpopulations. To determine
whether genetic switching at the spnD39III locus and the con-
sequent differential epigenetic modiﬁcation was selected for
in vivo, we analysed the frequencies of the various spnD39III
alleles in wild-type pneumococci during infection using a wild-
type D39 strain in which the SpnD39III locus is free to switch
between the six different allele variants. We developed a ﬂuor-
escent GeneScan assay (fragment length analysis) using PCR
followed by restriction digest of the products, speciﬁcally for this
purpose, which allows the simultaneous identiﬁcation and
quantiﬁcation of all six alleles within the bacterial population (an
example of the methodology, and exemplar results are shown in
Supplementary Fig. 6a–c; veriﬁcation of this method is shown in
Supplementary Fig. 6d,e). The D39 inoculum that was used to
challenge mice intravenously (Fig. 4d,e) was found to be pre-
dominantly spnD39IIIE (12% spnD39IIIA, 13% spnD39IIIB, 4%
spnD39IIID and 71% spnD39IIIE; Fig. 4h). In contrast, the
pneumococci reisolated from mice showed a clear change in their
SpnIIID39 allele type, with samples at 4 and 30 h after challenge
having changed to a predominantly SpnD39IIIA state (Fig. 4h),
clearly indicating selection for speciﬁc spnD39III alleles during
infection20. Most striking was the change away from SpnIIID39E
to SpnIIID39A in all of the blood samples from mice infected
with the SpnD39IIIE-dominated inoculum. This suggests a
deﬁnitive selection for the SpnD39IIIA allele in blood even as
early as 4 h after challenge. Variations in allele frequency
compared with inoculum were not detected in nasopharyngeal
samples from the carriage experiment (Fig. 4g), indicating there is
no such selection for alternate SpnD39III alleles in this
environment. For these data, we conﬁrmed that when allele
quantiﬁcation was performed directly on all nasal lavage samples,
it yielded substantially the same allele composition as when
testing ﬁrst passage bacterial colonies grown from these samples
(Supplementary Table 5).
Discussion
Here, we have described a genetic switch that results in the
presence of six different bacterial subpopulations each with
distinct Type I RM target speciﬁcities and distinct epigenetic
proﬁles. Such switchable Type I systems have previously been
described, but these reports did not provide evidence for
differential methylation or for phenotypic impact6,11,12. The
SpnD39III system is distinct from the absolute ON/OFF
switching of the Type III RM regulatory systems described in
Gram-negative bacterial pathogens that switch between
methylated and unmethylated states21; however, it does ﬁt the
deﬁnition of a phase variable regulon (‘phasevarion’)4,22.
Importantly, the pneumococcal subpopulations identiﬁed in the
present study exhibit phenotypic changes, including opacity
phase variation differences, which have a major impact on
bacterial virulence. This system provides a contingency
mechanism for adaptation to changing environments21, such as
those that are encountered during progression from
asymptomatic colonization to invasive pneumococcal disease.
Indeed, the SpnD39III system appears to be a central regulatory
mechanism governing the ﬁtness of the pneumococcus in distinct
host niches. Since the spnD39III allele composition of a
pneumococcal population signiﬁcantly inﬂuences important
phenotypes, and can also change rapidly, it is essential that all
previous and future in vitro and in vivo studies should be
interpreted in the context of this potential for switching between
these heretofore undetected and uncharacterized differentiated
pneumococcal subpopulations. We believe these ﬁndings
represent a new paradigm in gene regulation in bacteria and
therefore are of great signiﬁcance to the infectious disease ﬁeld.
Methods
Nomenclature of the RM systems identiﬁed. The well-described pneumococcal
enzyme DpnI, originally clonded from a non-encapsulated D39 derivative23,24, will
be named in this paper SpnD39ORF1631P (Table 1), to comply with current
practice to use for each strain producing restriction enzymes an unique acronym.
The other two Type II RM systems are annotated in the genome sequence of
S. pneumoniae strain R6 (GenBank nucleotide database accession code AE007317)
as SpnI (Restriction Enzyme database (REBASE) annotation SpnD39ORF1260P)
and SpnII (REBASE annotation SpnD39ORF1079AP)7. This led us to annotate the
phase variable Type I RM system as SpnD39III (SpnD39ORF454P) (GenBank
accession codes KJ955483-6 and KJ398403-4). Wherever possible, we have
followed the nomenclature outlined in the REBASE for S. pneumoniae D39 (ref. 9).
Recombinant variants of the speciﬁcity subunit S.SpnD39III will be referred to
using the sufﬁx A–F. The second Type I RM system of D39 is not functional and
since we have characterized it in strains WCH16 and WCH43, we have named the
relevant variants S.SpnWCH16IVA (GenBank accession code KM030255) and
SpnWCH43IVB (GenBank accession code KM030256). For the Type IV RM
system, the only one currently without proven function, we have maintained the
denomination SpnD39McrBCP already in REBASE9.
Ethics statement. Animal experiments performed in Italy were approved by the
Comitato Etico dell’Azienda Ospedaliera Universitaria Senese (Ethics Committee
of the University Hospital of Siena, Siena, Italy). The animal experiments per-
formed in Australia were approved by the University of Adelaide Animal Ethics
Committee. The animal experiments performed in the UK were approved by the
University of Leicester Ethics Committee in accordance with the U.K Home Ofﬁce.
All experiments were done in accordance with respective national and institutional
guidelines.
Bacterial strains and growth conditions. All pneumococcal strains were derived
from strain D39 (serotype 2) and were routinely cultured on Tryptic Soy Broth agar
plates with 3% v/v deﬁbrinated horse blood at 37 C in a 5% CO2 incubator. For
colony morphology, the analysis plates contained 200Uml 1 of catalase (Sigma,
Germany) instead of blood. E. coli DH5a cells were grown according to standard
protocols. The Streptococcus–E. coli shuttle vector pDP28 (GenBank accession code
KJ395591) (ref. 25) was selected in E. coli using 10mgml 1 of chloramphenicol
(Sigma) and in pneumococci using 5 mgml 1 of erythromycin (Sigma).
Construction of mutants. Recombinant D39 derivatives included a series of
strains which stably expressed only one of the six spnD39III variants (spnD39IIIA-
F) with a deletion of the truncated hsdS genes (S1.SpnD39III and S2.SpnD39III).
Strains carrying either pDP28 (GenBank accession code KJ395591) or its deriva-
tives pMRO1, pMRO2, or pMRO3 (see below) were derived from the SpnD39IIIA-
D variant strains. All pneumococcal mutants were made following a multi-layer
plating protocol for transformation as described elsewhere26. The SpnD39III
variants were originated by transforming PCR generated fragments into naturally
competent pneumococcal cells. In brief, ﬂanking segments of the gene to be deleted
were ampliﬁed with primers having 20 bp tails complementary to an add9
spectinomycin resistance cassette. Reampliﬁcation of the ﬂanking fragments
together with the resistance cassette allowed synthetic constructs to be produced by
PCR. Following transformation, representative transformants, selected using
200 mgml 1 of spectinomycin (Sigma), were chosen. To construct pneumococcal
mutants, the primers used included: 50-GCAGTCTAAGCCATCAAATAC-30 and
50-GATCCACTAGTTCTAGAGCTTTCTGCCTGTAATTGTTCATC-30 for the
upstream ﬂanking segment; 50-GTATCGCTCTTGAAGGGAACACTTCGGCGAT
TTTCTGA-30 and 50-CGTGCGGTGGAATTTCTAT-30 for the downstream
ﬂanking segment for the spnD39IIIA and spnD39IIID variants; 50-GTATCGCTC
TTGAAGGGAAGAGCATGTAGAAATCGGTTAT-30 and 50-TAATGCTTAAAT
CGCCCTTCT-30 for the downstream ﬂanking segment for the spnD39IIIB and
spnD39IIIC variants; 50-GGTGTTAGAATTATACGTGGTGG-30 and 50-GTATC
GTCTTGAAGGGAACATTAAATAGTACCAGTATCTCCG-30 for the
downstream ﬂanking segment for the spnD39IIIE and spnD39IIIF variants;
50-GTATCGCTCTTGAAGGGAAGCCATCGTTTGGTCTACTAAGATGT-30 and
50-AGCATATCGCTTACGAAGAATACTT-30 for the downstream ﬂanking
segment for the SpnD39III deletion mutant; and 50-GCTCTAGAACTAGTGG
ATC-30 and 50-TTCCCTTCAAGAGCGATAC-30 for the aad9 cassette. Constructs
were conﬁrmed by Sanger sequencing and in the case of the SpnD39IIIA-D variant
strains also by whole-genome Illumina sequencing (Institute of Applied Genomics,
Udine, Italy). The sequences of the spnD39III loci in the locked mutant strains have
been deposited in the GenBank nucleotide database with accession codes KJ955483
to KJ955486, KJ398403 and KJ398404). For construction of pDP28 derivatives the
plasmid was originally extracted from E. coli strain DH5a (HiSpeed Plasmid
Puriﬁcation, Qiagen). Site-directed mutagenesis by inverted PCR was performed on
pDP28 using primers 50-CACCAAATGTAGCACCTGAAAGCAAATTCGACCC
GGT-30 and 50-CAGGTGCTACATTTGGTGCCGCTTATTATCACTTATTC
AGG-30 to construct pMRO1, primers 50-CACCACGGTCACACTGAAAGCAAA
TTCGACCCGGT-30 and 50-CAGTGTGACCGTGGTGCCGCTTATTATCACTT
ATTCAGG-30 to construct pMRO2 and primers 50-CCAGAACCTCTTACGTG
GGTTCCAACTTTCACCATAATG-30 and 50-CACGTAAGAGGTTCTGGGCCG
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ATCAACGTCTCATT-30 to construct pMRO3. The modiﬁed plasmids were then
transformed into E. coli by standard methods.
Transformation of pneumococci. Transformation experiments to demonstrate
methylation and restriction were performed using the same transformation pro-
tocol as above26. Plasmid pDP28 (extracted from E. coli DH5a as above) and its
derivatives pMRO01, pMRO02 and pMRO03 (Supplementary Fig. 4) were
transformed into pneumococcal variant strains SpnD39IIIA-D. Plasmids were then
reextracted using an alkaline lysis protocol, as described elsewhere27, and each
retransformed into the locked strains. The quantity of plasmid used for
transformation was 10 ng of plasmid DNA for 100 ml of competent cells.
To test chromosomal insertion of linear PCR fragments during transformation
(Supplementary Fig. 2f), the mutant gene SPD_0661 containing a kanamycin
cassette (aphIII) (ref. 28) was ampliﬁed using the primers 50-CGGTAAGGCTTTG
ATGGTAGTTA-30 and 50-GGTTTACCTTCAAGACTTACTGTG-30 . This
fragment contained one SpnD39IIIA recognition site. Modiﬁed fragments
were constructed with two SpnD39IIIA sites in all the possible orientations:
co-directional, non-co-directional in tail-to-tail orientation and non-co-directional
in head-to-head orientation. This mutagenesis was performed using the primers
50-CGAATGTAGCACCTGAGCTGGGGATCCGTTTGAT-30 and 50-CAGGT
GCTACATTCGTGAACCTGAGATAATCCCTACG-30 for co-directional site
orientation, 50-CAGGTGCTACATTCGAGCTGGGGATCCGTTTGAT-30 and
50-CGAATGTAGCACCTGTGAACCTGAGATAATCCCTACG-30 for tail-to-tail
sites and 50-CAGGTGCTACATTCGGCCTACGAGGAATTTGTATCTTC-30 and
50-CGAATGTAGCACCTGGCTCGGGACCCCTATCTAGCGA-30 for head-to-
head oriented sites. The quantity of PCR DNA used for transformation was 100 ng
of DNA for 100 ml of competent cells and transformants were selected with
500mgml 1 of kanamycin.
Allele quantiﬁcation. The variant alleles of hsdS in wild-type D39 were quantiﬁed
utilizing an allele scan protocol (Supplementary Fig. 6). The whole hsdS locus was
PCR ampliﬁed (4.2 kb) from extracted genomic DNA utilizing primers 50-
CCATTATCTATAGGCGTATTTTTACG30- and FAM–50-GGAAACTGAGA
TATTTCGTGGTG-30 (where FAM is 6-ﬂuorescein amidite). The PCR products
were then digested with both DraI and PleI (New England Biolabs, MA, USA). This
digestion was predicted to yield different sized FAM-labelled fragments for each of
the variant forms. The pool of restriction fragments was run on an ABI prism Gene
Analyser (Life Technologies). The area of the peak given by each labelled fragment,
each corresponding to the prevalence of one of the variant forms, was quantiﬁed
using Peak Scanner v1.0.
Genome and gene expression analysis. The genomic analysis that allowed the
identiﬁcation of the SpnD39III system was performed using Artemis Comparison
Tool utilizing S. pneumoniae D39 (GenBank nucleotide database accession code
NC_008533.1) and TIGR4 (accession code NC_003028.3) genome sequences.
Whole-genome sequencing was performed for strains SpnD39IIIA-D (Institute of
Applied Genomics, Udine, Italy) using an Illumina Genome Analyzer II platform
(Illumina, San Diego, CA). Analysis of these sequences was performed using the
programs FastQC for analysis of the quality of the reads, Trimmomatic (version
0.30) DynamicTrim for quality improvements, Mosaik and SamTools for align-
ment and VarScan for detection of SNPs, insertions and deletions. For gene
expression, pneumococcal strains were grown to mid-log phase (OD590 approxi-
mately 0.15). 2ml of cells were harvested by centrifugation at 10,000 r.p.m. for
15min and resuspended in 90 ml of TE with 10 ml of lysozyme. The NucleoS-
pinRNA II kit (Macherey-Nagel, Germany) was used for RNA extraction following
the manufacturer’s protocol. Frozen RNA samples were sent to the Institute of
Applied Genomics (University of Udine, Italy) for RNA-seq analysis using an
Illumina Genome Analyzer II platform (Illumina). RNA-Seq fastq ﬁles were
trimmed using ERNE, read mapping to the reference genome D39 was performed
using Tophat, and transcript abundance and differential expression analyses were
carried out using Cufﬂinks and the R package cummeRbund. Three independent
replicas were used for each sample. The RNA-seq data were deposited in the NCBI
GEO database with accession code GSE55182.
Methylome analysis. DNA was extracted from overnight cultures in TSB from
each of the different variants using the High Pure PCR Template Preparation kit
(Roche, Italy) and sent to Paciﬁc Biosciences (Menlo Park, CA, USA) where
methylome data was obtained by SMRT. SMRTbell libraries were prepared as
previously described29. Brieﬂy, gDNA was sheared to an average length of
approximately 10 kb using g-TUBEs (Covaris, Woburn, MA, USA), treated with
DNA damage repair mix, end repaired and ligated to hairpin adapters.
Incompletely formed SMRTbell templates were digested using Exonuclease III
(New England Biolabs) and Exonuclease VII (Affymetrix, OH, USA). Sequencing
was carried out on the PacBio RS II (Menlo Park, CA, USA) using standard
protocols for long insert libraries. Methylation sites of variants SpnIIIA-C were
experimentally conﬁrmed by protection of pDP28 DNA from digestion by
methylation sensitive enzymes with overlapping target speciﬁcity. Plasmid DNA
for these experiments was extracted from strains expressing a single SpnD39III
variant and shown by SMRT sequencing to methylate one single SpnD39III target.
When extracted from pneumococcal strains, a manual protocol of alkaline lysis was
used. Plasmid pDP28 was originally extracted from an E. coli DH5a strain using
the HiSpeed Plasmid Midi Kit from Qiagen (Italy). Enzymes used included AcuI
(50-CTGAAG-30) whose target sites can overlapp SpnIIIA target sites; SfuI
(50-TTCGAA-30), overlapping SpnIIIB; and BsaA1 (50-TACGTG-30), overlapping
SpnIIIC (all from Fermentas, Germany). Protection from cleavage was visualized
on ethidium bromide stained agarose gels.
Uronic acid quantiﬁcation. Pneumococcal capsule samples were prepared as
previously described30. In brief, deoxycolate-lysed pneumococci were treated by
adding 100U of mutanolysin (Sigma, Australia), 50U DNaseI (Roche, Australia)
and 50mg RNaseA and incubating overnight at 37 C, followed by treatment with
100 mg of proteinase K at 56 C for 4 h. Uronic acid was then quantitated
colourimetrically, as described previously30.
Quantitative western blot. Relative expression of LuxS was determined by
quantitative western blot analysis of whole-cell lysates. The total protein in the
lysates was determined using the BCA Protein Assay kit (Thermo Scientiﬁc,
Australia). Bands on western blots were detected uisng anti-LuxS polyclonal
murine antiserum at a dilution of 1:2,000 and donkey anti-mouse IRDye 800 CW
secondary antibody (LI-COR Biosciences, USA) at a dilution of 1:50,000. The blot
was scanned and LuxS expression was quantiﬁed using the Odyssey Infrared
Imaging System (LI-COR Biosciences).
Macrophage phagocytosis. Standard phagocytosis assays were performed as
previously described31. Spleen and bone marrow macrophages were isolated
from mice using a modiﬁed protocol20. RAW 264.7 were cultured in RPMI
medium (Deﬁned Hyclone, Logan, UT, USA) supplemented with 10% heat
inactivated fetal calf serum. At conﬂuence of 90%, 0.1ml of pneumococcus
cultured to OD590 0.25 were added. After 45min plates were washed and
reincubated with 10mg l 1 of penicillin and 200mgml 1 of gentamicin
(Sigma, Germany) for 30min. Intracellular bacteria were enumerated after lysis
with saponin 1%.
Experimental infections. Carriage experiments for variants SpnD39IIIA-D were
performed in Siena, Italy, with mice from Charles River (Italy). To evaluate
nasopharyngeal carriage, 15 groups of ﬁve female, 7 weeks old, BALB/c mice
(resistant to systemic pneumococcal infection) were infected intranasally (5 104
c.f.u. in 10ml PBS)32. Pneumococcal strains included the D39 wild type and the
strains expressing a single SpnD39III variant (SpnD39IIIA, SpnD39IIIB,
SpnD39IIIC or SpnD39IIID). At the time of killing (days 1, 3 and 7), nasal lavages
were performed. An equivalent protocol was followed for variants SpnD39IIIE and
F (using wild-type D39 as control), when performing intranasal infection at the
University of Leicester, UK, using groups of ﬁve female, 9 weeks old, BALB/c mice
supplied by Harlan (Bicester, UK). For the invasive disease model, performed in
Adelaide, Australia, female outbred 6-week-old CD-1 mice were inoculated
intravenously with 1 105 c.f.u. of the same pneumococcal strains as above (100 ml
inoculum)33,34. Groups of 12 mice were inoculated for each strain and blood was
collected by cheek bleeding at 4 and 30 h post infection. At 30 h, spleen, brain and
liver samples were also taken. Statistical signiﬁcance was calculated on log-
transformed data using the unpaired (two-tailed) t-test.
Mathematical analysis of target site distribution. Comparison of number of
target sites (markers): by using nucleotide frequencies, we can estimate the
expected number of each marker using the assumption that nucleotides are
distributed independently (that is, the probability of ﬁnding a speciﬁc nucleotide in
a speciﬁed position does not depend on nucleotides in other positions). We tested
the signiﬁcance of the differences between expected and observed numbers for each
marker site in both strands and in each strand separately by w2-test. To analyse the
positional relationship between markers, we compared the empirical distribution of
distances with the uniform distribution for relatively small distances (less than half
of the average distance). For this comparison, we calculated the cumulative dis-
tribution function for distances at the selected scale and used the Kolmogorov–
Smirnov test35. For the distances between the markers situated in different strands,
we used several samplings: the distances from the marker in the leading strand to
the downstream marker in the lagging strand (‘tail-to-tail’), the distances from the
marker in the leading strand to the upstream marker in the lagging strand (‘head-
to-head’) and the distances between markers in different strands, for both ‘tail-to-
tail’ and ‘head-to-head’ orientations (‘bidirectional’). If the empirical cumulative
density signiﬁcantly exceeded the corresponding uniform distribution at the
selected scale, then we concluded that the markers demonstrated attraction over
the short distance (prevalence of short distances). For additional validation of this
test, we use direct simulation. We also applied the Clark–Evans test36 and compare
the average distance to the nearest neighbours with the average for Poisson
distribution (that is 1/(2r), where r is the density of markers) with the proper
modiﬁcation for oriented pairs of markers in different strands.
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